Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Caca

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2011
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerA Schmittel, M Sebastian, L Fischer von Weikersthal, et al.
British Journal of Cancer|January 19, 2013
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancerA Atmaca, S-E Al-Batran, D Werner, et al.
Zeitschrift Fur Gastroenterologie|March 10, 2009
[Gastrointestinal oncology - therapy update 2008 / 2009]M P Ebert, C Auernhammer, K Caca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'M Haas, J T Siveke, M Schenk, et al.
ESMO Open|July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)K Heinrich, M Karthaus, S Fruehauf, et al.
Zeitschrift Fur Gastroenterologie|April 9, 2011
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]M Moehler, S-E Al-Batran, T Andus, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2011
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerA Schmittel, M Sebastian, L Fischer von Weikersthal, et al.
British Journal of Cancer|January 19, 2013
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancerA Atmaca, S-E Al-Batran, D Werner, et al.
Zeitschrift Fur Gastroenterologie|March 10, 2009
[Gastrointestinal oncology - therapy update 2008 / 2009]M P Ebert, C Auernhammer, K Caca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'M Haas, J T Siveke, M Schenk, et al.
ESMO Open|July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)K Heinrich, M Karthaus, S Fruehauf, et al.
Zeitschrift Fur Gastroenterologie|April 9, 2011
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]M Moehler, S-E Al-Batran, T Andus, et al.
Pageof 7